Challenges in drug development for functional gastrointestinal disorders. Part I: Functional dyspepsia

Neurogastroenterology and Motility

Volumn 18, Issue 5, 2006, Pages 346-353

  Andresen, V ^a   Camilleri, M ^a,b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Biomarker; Clinical trial design; Gastric accommodation; Gastric emptying

Indexed keywords

BIOLOGICAL MARKER; BOTULINUM TOXIN; CISAPRIDE; ERYTHROMYCIN; MOTILIDE; PROKINETIC AGENT; TEGASEROD; UNCLASSIFIED DRUG;

CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; DYSPEPSIA; ENZYME METABOLISM; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; KINETICS; PATHOPHYSIOLOGY; PERFORMANCE; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; SCREENING; SENSITIVITY ANALYSIS; SOMATIZATION; STOMACH EMPTYING; VALIDATION PROCESS; VISCERAL PAIN;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS; DRUG DESIGN; DYSPEPSIA; GASTROINTESTINAL AGENTS; HUMANS; RESEARCH DESIGN;

EID: 33645811289     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00778.x     Document Type: Review

References (32)

1. Thomson AB Barkun AN Armstrong D et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study Aliment Pharmacol Ther 2003 17 1481 91
2. Talley NJ Stanghellini V Heading RC Koch KL Malagelada JR Tytgat GN Functional gastroduodenal disorders Gut 1999 45 Suppl. 2 II37 42
3. Castillo EJ Camilleri M Locke GR et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia Clin Gastroenterol Hepatol 2004 2 985 96
4. Camilleri M Dubois D Coulie B et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study Clin Gastroenterol Hepatol 2005 2005 3 543 52
5. Tack J Caenepeel P Arts J Lee KJ Sifrim D Janssens J Prevalence of acid reflux in functional dyspepsia and its association with symptom profile Gut 2005 54 1370 6
6. Stanghellini V Tosetti C Paternic A et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia Gastroenterology 1996 110 1036 42
7. Sarnelli G Caenepeel P Geypens B Janssens J Tack J Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia Am J Gastroenterol 2003 98 783 8
8. Delgado-Aros S Camilleri M Cremonini F Ferber I Stephens D Burton DD Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia Gastroenterology 2004 127 1685 94
9. Tack J Piessevaux H Coulie B Caenepeel P Janssens J Role of impaired gastric accommodation to a meal in functional dyspepsia Gastroenterology 1998 115 1346 52
10. Tack J Functional dyspepsia: impaired fundic accommodation Curr Treat Options Gastroenterol 2000 3 287 94
11. Bredenoord AJ Chial HJ Camilleri M Mullan BP Murray JA Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms Clin Gastroenterol Hepatol 2003 1 264 72
12. Distrutti E Fiorucci S Hauer SK Pensi MO Vanasia M Morelli A Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia Aliment Pharmacol Ther 2002 16 613 22
13. Tack J Caenepeel P Corsetti M Janssens J Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention Gastroenterology 2004 127 1058 66
14. Tack J Caenepeel P Piessevaux H Cuomo R Janssens J Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia Gut 2003 52 1271 7
15. Cuomo R Sarnelli G Grasso R et al. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships Scand J Gastroenterol 2001 36 1030 6
16. De Schepper HU Cremonini F Chitkara D Camilleri M Assessment of gastric accommodation: overview and evaluation of current methods Neurogastroenterol Motil 2004 16 275 85
17. Gonenne J Castillo EJ Camilleri M et al. Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia Neurogastroenterol Motil 2005 17 44 50
18. Talley NJ Verlinden M Geenen DJ et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial Gut 2001 49 395 401
19. Talley NJ Verlinden M Snape W et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial Aliment Pharmacol Ther 2000 14 1653 61
20. Fischler B Tack J De Gucht V et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia Gastroenterology 2003 124 903 10
21. Tack J Bisschops R Sarnelli G Pathophysiology and treatment of functional dyspepsia Gastroenterology 2004 127 1239 55
22. Moayyedi P Soo S Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia Cochrane Database Syst Rev 2005 CD002096
23. Moayyedi P Soo S Deeks J Delaney B Innes M Forman D Pharmacological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 2004 CD001960
24. Tougas G Chen Y Coates G et al. Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting Am J Gastroenterol 2000 95 78 86
25. Viramontes BE Kim DY Camilleri M et al. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying Neurogastroenterol Motil 2001 13 567 74
26. Corinaldesi R Stanghellini V Raiti C Rea E Salgemini R Barbara L Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis Gut 1987 28 300 5
27. Camilleri M Malagelada JR Abell TL Brown ML Hench V Zinsmeister AR Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction Gastroenterology 1989 96 704 12
28. Janssens J Peeters TL Vantrappen G et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies N Engl J Med 1990 322 1028 31
29. Tack J Coremans G Janssens J A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders Drug Saf 1995 12 384 92
30. Tack J Vos R Janssens J Salter J Jauffret S Vandeplassche G Influence of tegaserod on proximal gastric tone and on the perception of gastric distension Aliment Pharmacol Ther 2003 18 1031 7
31. Veldhuyzen van Zanten SJ Talley NJ Bytzer P Klein KB Whorwell PJ Zinsmeister AR Design of treatment trials for functional gastrointestinal disorders Gut 1999 45 Suppl. 2 II69 77
32. Chial HJ Camilleri C Delgado-Aros S et al. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health Neurogastroenterol Motil 2002 14 249 53